The Latest SPAC News and Rumors: September 25, 2023
Below is a daily summary of links to the latest SPAC news and rumors gathered across the web.
Conduit’s $1.2bn Nasdaq listing deals another blow to London
A British biopharmaceuticals business has completed a deal to list on Nasdaq, delivering a further blow to the London Stock Exchange which has struggled to persuade fast-growing companies to float in the UK.
Conduit Pharmaceuticals completed its merger with Murphy Canyon Acquisition Corp, a Nasdaq-listed special purpose acquisition company, after the US market closed on Friday. The deal placed a value of $1.2 billion on the business. The new combined company has been named Conduit Pharmaceuticals.
READWilson, Goodwin on Cheche Group’s de-SPAC merger, achieving NASDAQ listing
Cheche’s U.S. listing represents the first case of a VIE structure overseas listing project completed under the Administrative Measures of Overseas Securities Offering and Listing by Domestic Companies. According to the China Securities Regulatory Commission (CSRC) website, Cheche received its approval on September 14. […]
Cheche Group, founded in 2014, aims to transform China’s auto insurance market and digitise the end-to-end insurance purchasing process in a transparent, universal, and efficient manner. Currently, Cheche has 130 service centres nationwide, with research and development centres located in Beijing and Guangzhou.